300143 盈康生命
已收盘 05-16 15:00:00
资讯
新帖
简况
体系化提升患者营养水平,盈康生命旗下医院推进营养诊疗抗癌
证券之星 · 05-16 18:55
体系化提升患者营养水平,盈康生命旗下医院推进营养诊疗抗癌
4月30日盈康生命发布公告,其股东增持243.57万股
证券之星 · 04-30
4月30日盈康生命发布公告,其股东增持243.57万股
盈康生命(300143.SZ)控股股东累计增持公司243.57万股
智通财经 · 04-30
盈康生命(300143.SZ)控股股东累计增持公司243.57万股
盈康生命一季度营收增长显著,归母净利润环比大涨310%
证券之星 · 04-25
盈康生命一季度营收增长显著,归母净利润环比大涨310%
东吴证券:给予盈康生命买入评级
证券之星 · 04-25
东吴证券:给予盈康生命买入评级
盈康生命最新公告:一季度净利润2622.59万元 同比下降33.69%
证券之星 · 04-25
盈康生命最新公告:一季度净利润2622.59万元 同比下降33.69%
盈康生命(300143.SZ)发布一季度业绩,净利润2622.59万元,下降33.69%
智通财经 · 04-25
盈康生命(300143.SZ)发布一季度业绩,净利润2622.59万元,下降33.69%
发布首份《低碳医疗行动指引》,盈康生命深入推进低碳运营
新浪证券 · 04-25
发布首份《低碳医疗行动指引》,盈康生命深入推进低碳运营
盈康生命净利飙升117%结束两连亏 内生外延齐发力医疗器械营收翻倍
市场资讯 · 04-24
盈康生命净利飙升117%结束两连亏 内生外延齐发力医疗器械营收翻倍
华安证券:给予盈康生命买入评级
证券之星 · 04-23
华安证券:给予盈康生命买入评级
共“盈”可持续未来,盈康生命披露2023年可持续发展报告
新浪证券 · 04-23
共“盈”可持续未来,盈康生命披露2023年可持续发展报告
中邮证券:给予盈康生命买入评级
证券之星 · 04-23
中邮证券:给予盈康生命买入评级
【机构调研记录】申万菱信基金调研中际旭创、盈康生命等3只个股(附名单)
证券之星 · 04-23
【机构调研记录】申万菱信基金调研中际旭创、盈康生命等3只个股(附名单)
盈康生命(300143.SZ)发2023年度业绩,净利润1亿元,同比扭亏为盈
智通财经网 · 04-21
盈康生命(300143.SZ)发2023年度业绩,净利润1亿元,同比扭亏为盈
引入新技术!盈康生命旗下四川友谊医院开展首例肿瘤微波消融术
新浪证券 · 03-22
引入新技术!盈康生命旗下四川友谊医院开展首例肿瘤微波消融术
助力癌防事业,盈康生命旗下四川友谊医院获批国家级AAA级试点单位
新浪证券 · 03-15
助力癌防事业,盈康生命旗下四川友谊医院获批国家级AAA级试点单位
盈康生命旗下友谊医院正式挂牌“成都市抗癌协会副会长单位”
新浪证券 · 03-09
盈康生命旗下友谊医院正式挂牌“成都市抗癌协会副会长单位”
盈康生命(300143.SZ)控股股东盈康医投拟1000万元至2000万元实施增持
智通财经网 · 02-19
盈康生命(300143.SZ)控股股东盈康医投拟1000万元至2000万元实施增持
盈康生命:向特定对象发行股票申请获得深交所受理
财华社 · 2023-11-24
盈康生命:向特定对象发行股票申请获得深交所受理
加载更多
公司概况
公司名称:
盈康生命科技股份有限公司
所属行业:
卫生
上市日期:
2010-12-09
主营业务:
盈康生命科技股份有限公司主营业务为以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司主要产品和服务有伽玛刀及医疗服务。公司在医疗器械方面:国内头部伽玛刀领域龙头企业,并率先实现大型放疗设备自主出口,成功打破国际大型公司全球垄断地位。
发行价格:
36.00
{"stockData":{"symbol":"300143","market":"SZ","secType":"STK","nameCN":"盈康生命","latestPrice":8.14,"timestamp":1715843016000,"preClose":8.22,"halted":0,"volume":3398800,"delay":0,"floatShares":642000000,"shares":642000000,"eps":0.1357,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.08,"latestTime":"05-16 15:00:00","open":8.2,"high":8.3,"low":8.11,"amount":27864000,"amplitude":0.0231,"askPrice":8.14,"askSize":44,"bidPrice":8.12,"bidSize":132,"shortable":0,"etf":0,"ttmEps":0.1357,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715909400000},"adr":0,"adjPreClose":8.22,"symbolType":"stock","openAndCloseTimeList":[[1715823000000,1715830200000],[1715835600000,1715842800000]],"highLimit":9.04,"lowLimit":7.4,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":642167010,"pbRate":3.86,"roa":"--","roe":"1.91%","epsLYR":0.16,"committee":0.184345,"marketValue":5227000000,"floatMarketCap":5227000000,"peRate":59.985261,"changeRate":-0.0097,"turnoverRate":0.0053,"status":1},"requestUrl":"/m/hq/s/300143","defaultTab":"news","newsList":[{"id":"2435673730","title":"体系化提升患者营养水平,盈康生命旗下医院推进营养诊疗抗癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2435673730","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435673730?lang=zh_cn&edition=full","pubTime":"2024-05-16 18:55","pubTimestamp":1715856903,"startTime":"0","endTime":"0","summary":"近日,正在乳腺癌康复期的李女士(化名)辗转来到盈康生命旗下四川友谊医院进行营养治疗。打通全链条提升患者营养水平据蒋林君介绍,2023年,四川友谊医院肿瘤营养病房开科,与临床科室共同致力于为患者提供营养治疗服务:依托涵盖营养筛查、评估、治疗等在内的完整管理体系,提供“肿瘤营养标准化治疗方案”。为解决这一问题,四川友谊医院打通了患者住院期间和出院后康复阶段在内的全链条服务,有效提升患者营养水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024051600028629.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431534047","title":"4月30日盈康生命发布公告,其股东增持243.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431534047","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431534047?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:01","pubTimestamp":1714482090,"startTime":"0","endTime":"0","summary":"证券之星消息,4月30日盈康生命发布公告《盈康生命:北京市金杜(青岛)律师事务所关于盈康生命科技股份有限公司控股股东增持公司股份的法律意见书》,其股东青岛盈康医疗投资有限公司于2024年2月20日至2024年4月29日间合计增持243.57万股,占公司目前总股本的0.3793%,变动期间该股股价上涨0.73%,截止4月29日收盘报8.3元。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000050481.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431344387","title":"盈康生命(300143.SZ)控股股东累计增持公司243.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431344387","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431344387?lang=zh_cn&edition=full","pubTime":"2024-04-30 20:32","pubTimestamp":1714480354,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盈康生命(300143.SZ)发布公告,2024年2月20日至2024年4月29日,公司控股股东盈康医投已通过集中竞价方式累计增持了公司股份243.57万股,占公司当前总股本的0.38%,累计增持金额为1999.94万元,已达增持计划金额下限。盈康医投已完成本次增持计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116510.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430474906","title":"盈康生命一季度营收增长显著,归母净利润环比大涨310%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430474906","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430474906?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:52","pubTimestamp":1714038740,"startTime":"0","endTime":"0","summary":"4月25日,盈康生命公布了其2024年第一季度的财务报告,展现了公司在当前市场环境下的稳健经营和高质量发展态势。在一季度,盈康生命实现营收4.16亿元,同比增长15.17%,归母净利润0.26亿元,环比增长310.98%,显示出公司收入稳中有升,盈利能力持续巩固。盈康生命一季度的营收增长得益于公司在医疗服务和医疗器械领域的持续创新和优化产业结构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024042500038412.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430474885","title":"东吴证券:给予盈康生命买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430474885","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430474885?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:45","pubTimestamp":1714038326,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司近期对盈康生命进行研究并发布了研究报告《2023年年报业绩点评:收入恢复快速增长,利润业绩扭亏为盈》,本报告对盈康生命给出买入评级,当前股价为7.95元。考虑到公司业务版图与收入规模持续扩张,2024年有望进入利润业绩加快增长阶段,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级4家;过去90天内机构目标均价为10.12。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500038200.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430471804","title":"盈康生命最新公告:一季度净利润2622.59万元 同比下降33.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430471804","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430471804?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:37","pubTimestamp":1714037836,"startTime":"0","endTime":"0","summary":"盈康生命公布2024年第一季度报告,报告期营业收入4.16亿元,同比增长15.17%;归属于上市公司股东的净利润2622.59万元,同比下降33.69%;基本每股收益0.0410元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500036898.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430730074","title":"盈康生命(300143.SZ)发布一季度业绩,净利润2622.59万元,下降33.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430730074","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430730074?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:03","pubTimestamp":1714035805,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盈康生命(300143.SZ)发布2024年第一季度报告,该公司营业收入为4.16亿元,同比增长15.17%。归属于上市公司股东的净利润为2622.59万元,同比减少33.69%。归属于上市公司股东的扣除非经常性损益的净利润为2382.46万元,同比减少38.55%。基本每股收益为0.041元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109873.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430265674","title":"发布首份《低碳医疗行动指引》,盈康生命深入推进低碳运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2430265674","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2430265674?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:54","pubTimestamp":1714028040,"startTime":"0","endTime":"0","summary":"现场,海尔集团旗下大健康生态品牌盈康一生旗下上市公司盈康生命发布《低碳医疗行动指引》。据业内专家介绍,这是内地医疗行业首份将低碳和医疗融合的行动指引。 承接国家战略和各利益相关方的需求,盈康生命近年来持续探索医疗机构低碳运营。此次发布的《低碳医疗行动指引》便是以“碳达峰、碳中和”为旗帜引领,用实际行动履行社会职责。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/hk/2024-04-25/doc-inaszpiy6061463.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2024-04-25/doc-inaszpiy6061463.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429344124","title":"盈康生命净利飙升117%结束两连亏 内生外延齐发力医疗器械营收翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2429344124","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429344124?lang=zh_cn&edition=full","pubTime":"2024-04-24 07:26","pubTimestamp":1713914760,"startTime":"0","endTime":"0","summary":" 4月22日,盈康生命发布2023年年报,公司营收、净利润均创新高,其中营收达14.71亿元,同比增长27.2%,净利润1亿元,同比增长116.9%。据iFinD显示,盈康生命毛利率从2022年的26.53%上升至2023年的28.57%。 据悉,盈康生命成立于1998年,主营业务包括医疗服务和医疗器械两大板块。2023年,盈康生命研发投入5224万元,同比大增86.35%。财报显示,2023年,盈康生命医疗器械板块实现营收3.22亿元,同比增长102%,五年复合增长率达128.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-04-24/doc-inaswtpc1367778.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-04-24/doc-inaswtpc1367778.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429196116","title":"华安证券:给予盈康生命买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429196116","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429196116?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:46","pubTimestamp":1713883571,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,陈珈蔚近期对盈康生命进行研究并发布了研究报告《业绩符合预期,业务发展进入高质量新周期》,本报告对盈康生命给出买入评级,当前股价为7.75元。公司经营及托管医院的学科能力提升,报告期内手术量达到24,178例,同比提升20%,其中三、四级手术量同比提升20%,占比维持70%以上。最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级2家;过去90天内机构目标均价为10.12。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300043902.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429169879","title":"共“盈”可持续未来,盈康生命披露2023年可持续发展报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2429169879","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2429169879?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:18","pubTimestamp":1713863880,"startTime":"0","endTime":"0","summary":"4月21日,盈康生命披露了《2023年度可持续发展报告》,这是公司披露的第5份报告。 报告期内,盈康生命进一步践行可持续发展理念,将可持续发展融入公司的日常经营当中,并提出“成为可持续发展绩效领先的医疗健康解决方案服务商”的ESG战略目标。 诚信共“盈”,夯实发展基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/2024-04-23/doc-inasvfmy8031658.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/2024-04-23/doc-inasvfmy8031658.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429133419","title":"中邮证券:给予盈康生命买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429133419","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429133419?lang=zh_cn&edition=full","pubTime":"2024-04-23 10:44","pubTimestamp":1713840241,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,龙永茂近期对盈康生命进行研究并发布了研究报告《医疗服务及器械板块均取得佳绩,高质量发展迈入新台阶》,本报告对盈康生命给出买入评级,当前股价为7.55元。 盈康生命 收入、利润快速增长,盈利能力稳步提升 公司发布2023年年报:2023年公司实现营业收入14.71亿元,归母净利润1.00亿元,扣非归母净利润1.04亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300020701.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429185967","title":"【机构调研记录】申万菱信基金调研中际旭创、盈康生命等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2429185967","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429185967?lang=zh_cn&edition=full","pubTime":"2024-04-23 08:02","pubTimestamp":1713830568,"startTime":"0","endTime":"0","summary":";公司整形美容科作为四川友谊医院特色科室,具有四级手术资质3)和而泰 个股亮点:国内智能控制器行业龙头企业;公司主营业务包括智能控制器;公司智能化业务板块与小米有业务合作申万菱信基金成立于2004年,截至目前,资产管理规模(全部)851.81亿元,排名63/203;资产管理规模(非货币)851.81亿元,排名61/203;管理基金数138只,排名47/203;旗下基金经理27人,排名47/203。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300011548.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429894869","title":"盈康生命(300143.SZ)发2023年度业绩,净利润1亿元,同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2429894869","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429894869?lang=zh_cn&edition=full","pubTime":"2024-04-21 16:17","pubTimestamp":1713687420,"startTime":"0","endTime":"0","summary":"盈康生命(300143.SZ)发布2023年年度报告,报告期内公司实现营业收入14.71亿元,同比增长27.20%;归属于上市公司股东的净利润1亿元,同比扭亏为盈;归属于上市公司股东扣除非经常性损益净利润1.04亿元,同比扭亏为盈;基本每股收益0.16元/股。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-21/doc-inasqtfq7239182.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-21/doc-inasqtfq7239182.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2421561348","title":"引入新技术!盈康生命旗下四川友谊医院开展首例肿瘤微波消融术","url":"https://stock-news.laohu8.com/highlight/detail?id=2421561348","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2421561348?lang=zh_cn&edition=full","pubTime":"2024-03-22 14:28","pubTimestamp":1711088880,"startTime":"0","endTime":"0","summary":"随着医疗技术的不断发展,当前的肿瘤治疗方式正朝着更加微创化、对患者生活质量影响更小的方向发展。3月20日,盈康生命旗下四川友谊医院开展了院内首例经胸壁穿刺肺肿瘤微波消融术,手术历时30分钟,这也是医院围绕肿瘤全周期管理、打造肿瘤优势特色方面的又一探索。四川友谊医院引入该技术后,可以为不愿意接受外科手术和中晚期不能手术的患者提供新的治疗选择。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-03-22/doc-inaperrr3984629.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-03-22/doc-inaperrr3984629.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419858996","title":"助力癌防事业,盈康生命旗下四川友谊医院获批国家级AAA级试点单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2419858996","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2419858996?lang=zh_cn&edition=full","pubTime":"2024-03-15 10:40","pubTimestamp":1710470400,"startTime":"0","endTime":"0","summary":"3月14日,在2024年四川省癌症防治工作会上,四川省“国家标准化癌症筛查推广与管理中心”试点单位名单公布,盈康生命旗下四川友谊医院获批AAA级管理中心试点单位。 下一步,盈康生命旗下四川友谊医院将进一步加强与国家癌症中心、四川省,成都市癌防中心的协作,深化肿瘤专业质控管理,推进“中国居民癌症防控行动”健康筛查平台的应用普及,扩大高危人群的评估筛查覆盖范围,促进区域内癌症防治体系再升级。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-03-15/doc-inankies1969540.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-03-15/doc-inankies1969540.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2418071699","title":"盈康生命旗下友谊医院正式挂牌“成都市抗癌协会副会长单位”","url":"https://stock-news.laohu8.com/highlight/detail?id=2418071699","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2418071699?lang=zh_cn&edition=full","pubTime":"2024-03-09 18:36","pubTimestamp":1709980560,"startTime":"0","endTime":"0","summary":"3月8日,成都市抗癌协会联合盈康生命旗下四川友谊医院共同开展妇女节健康科普联谊活动。活动中,成都市抗癌协会黄云春秘书长向友谊医院正式授牌“成都市抗癌协会副会长单位”。未来,友谊医院将在抗癌领域承担起更广泛的社会责任。 友谊医院将以此次授牌为契机,进一步深化其在抗癌领域的社会责任担当,加强与协会内各会员单位的深度合作与资源共享,为广大患者带来更为高效、精准的医疗服务体验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-03-09/doc-inamtmnq6058592.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-03-09/doc-inamtmnq6058592.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2412048181","title":"盈康生命(300143.SZ)控股股东盈康医投拟1000万元至2000万元实施增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2412048181","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2412048181?lang=zh_cn&edition=full","pubTime":"2024-02-19 19:22","pubTimestamp":1708341720,"startTime":"0","endTime":"0","summary":"盈康生命(300143.SZ)公告,公司获悉公司控股股东盈康医投于2024年2月8日及2月19日以集中竞价方式合计增持公司37万股股份,并计划自2024年2月20日起6个月内,以集中竞价方式继续增持公司股份,累计增持金额不低于1000万元,且不超过2000万元(均含本数且不包含交易费用)。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-19/doc-inaiqnma7924266.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-19/doc-inaiqnma7924266.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385842979","title":"盈康生命:向特定对象发行股票申请获得深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2385842979","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2385842979?lang=zh_cn&edition=full","pubTime":"2023-11-24 16:24","pubTimestamp":1700814240,"startTime":"0","endTime":"0","summary":"盈康生命(300143)公告称,公司于11月23日晚收到深圳证券交易所出具的《关于受理盈康生命科技股份有限公司向特定对象发行股票申请文件的通知》,深交所对公司报送的向特定对象发行股票的申请文件进行了核对,认为申请文件齐备,决定予以受理。公司本次向特定对象发行股票事项尚需通过深交所审核,并获得中国证监会作出同意注册的决定后方可实施。","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65605e2053243c0783753e6c","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-12-09","address":"山东省青岛市城阳区春阳路37号","stockEarnings":[{"period":"1week","weight":-0.0568},{"period":"1month","weight":0.1197},{"period":"3month","weight":-0.0611},{"period":"6month","weight":-0.2173},{"period":"1year","weight":-0.3262},{"period":"ytd","weight":-0.2342}],"companyName":"盈康生命科技股份有限公司","boardCode":"AI0083","perCapita":"37579股","boardName":"卫生","registeredCapital":"64216万元","compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":0.0384},{"period":"3month","weight":0.0895},{"period":"6month","weight":0.0223},{"period":"1year","weight":-0.0493},{"period":"ytd","weight":0.0496}],"survey":" 盈康生命科技股份有限公司主营业务为以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司主要产品和服务有伽玛刀及医疗服务。公司在医疗器械方面:国内头部伽玛刀领域龙头企业,并率先实现大型放疗设备自主出口,成功打破国际大型公司全球垄断地位。","serverTime":1715890247850,"listedPrice":36,"stockholders":"17088人(较上一季度增加0.22%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盈康生命,300143,盈康生命股票,盈康生命股票老虎,盈康生命股票老虎国际,盈康生命行情,盈康生命股票行情,盈康生命股价,盈康生命股市,盈康生命股票价格,盈康生命股票交易,盈康生命股票购买,盈康生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}